Aeterna Zentaris Inc. Gains 25.63%
Thu, Sep 30, 2021 at 05:30 PM
Aeterna Zentaris Inc. (AEZS:NASDAQ) jumped higher at $0.75, representing a gain of 25.6%. On Wed, Sep 29, 2021, AEZS:NASDAQ touched a New 2-Week Intraday High of $0.64. The stock got featured on our News Catalysts scanner on Wed, Sep 08, 2021 at 10:19 AM in the 'MISCELLANEOUS' category. From Wed, Sep 15, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Apr 26, 2021 at $1.17 with a volume of 12M+, and its share price has been moving sideways in recent weeks.
About Aeterna Zentaris Inc. (AEZS:NASDAQ)
AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women's health.
Top 10 Gainers:
- Conyers Park II Acquisition Corp. (CPAA:NASDAQ), 100%
- Superior Drilling Products, Inc. (SDPI:NYSEMKT), 60.55%
- PROG (PROG:NASDAQ), 40.74%
- Farmmi, Inc. (FAMI:NASDAQ), 36.03%
- ALZN (ALZN:NASDAQ), 35.09%
- OG (OG:NYSE), 30%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 25.63%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 22.95%
- Mediaco Holding Inc. (MDIA:NASDAQ), 20.08%
- Epsilon Energy Ltd. (EPSN:NASDAQ), 18.38%